We value your privacy

We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Privacy Policy

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

A DIVISION OF THE AMERICAN CHEMICAL SOCIETY
JOIN NOW
Menu

Recent developments in post-grant review preceedings

AUGUST 2017
Facebook Twitter Linkedin Reddit Tumblr Heart

Author

Krista E. Bianco
Kassandra Officer
Finnegan LLP

Presentation

254th ACS National Meeting – Washington, D.C.
“Recent Developments Regarding Post-Grant Challenges at the United States Patent & Trademark Office”

Abstract

This presentation will examine recent decisions from the Patent Trial and Appeal Board and the Court of Appeals for the Federal Circuit concerning the obviousness analysis for chemical and pharmaceutical patents, defenses to post-grant review proceedings, and the scope of the estoppel provision, among other recent developments.